Nursing Fro Laparoscopic vs. Open Hepatectomy

Overview

This study was divided into laparoscopic hepatectomy (observation group) and laparoscopic hepatectomy (control group).Compared two groups of age, sex, body mass index (BMI), tumor diameter, number of tumors (single/multiple), pathologic characteristics, HBsAg (positive/negative), liver function, AFP, Child – Pugh, grading, nursing method and comparison of two groups of patients after surgery (surgical incision length, intraoperative blood, intraoperative blood transfusion and transfusion volume, operation time) the number of cases of and postoperative rehabilitation (death cases, for the first time the meal time, anus exhaust time, analgesic bed, first time, the abdominal cavity drainage tube time, length of hospital stay, postoperative days and liver function index.Follow-up: the survival rates of the two groups were compared in six months, one year, two years, three years and five years.In this study, the initial selection of the minimum sample size of 30 cases, plus 20% inefficiencies, the final initial selection of 36 cases, and the later expansion of the sample size of 100 cases.The research date starts on October 1, 2017.

Full Title of Study: “Comparison of Efficacy and Nursing Between Laparoscopic Hepatectomy and Open Hepatectomy for Primary Liver Cancer”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: October 31, 2023

Detailed Description

Research design and methods: This study was divided into laparoscopic hepatectomy (observation group) and laparoscopic hepatectomy (control group).Compared two groups of age, sex, body mass index (BMI), tumor diameter, number of tumors (single/multiple), pathologic characteristics, HBsAg (positive/negative), liver function, AFP, Child – Pugh, grading, nursing method and comparison of two groups of patients after surgery (surgical incision length, intraoperative blood, intraoperative blood transfusion and transfusion volume, operation time) the number of cases of and postoperative rehabilitation (death cases, for the first time the meal time, anus exhaust time, analgesic bed, first time, the abdominal cavity drainage tube time, length of hospital stay, postoperative days and liver function index.Follow-up: the survival rates of the two groups were compared in six months, one year, two years, three years and five years.In this study, the initial selection of the minimum sample size of 30 cases, plus 20% inefficiencies, the final initial selection of 36 cases, and the later expansion of the sample size of 100 cases. Statistical methods: by means of SPSS 23.0 to analyze the data, all data after the normal test to choose the appropriate statistical methods, the normal distribution of measurement data in the two groups use surgery and postoperative recovery using two sets of samples t test, liver function index using analysis of variance, non-normal distribution using nonparametric test, count data chi-square test, P < 0.05 for the difference was statistically significant.Survival analysis was performed on two groups of patients.The research date starts on October 1, 2017.

Interventions

  • Procedure: lpaparoscopic hepatectomy
    • laparoscopic hepatectomy: laparoscopic hepatectomy for hepatocellular carcinoma.
  • Procedure: open hepatectomy
    • open hepatectomy: open hepatectomy for hepatocellular carcinoma

Arms, Groups and Cohorts

  • laparoscopic hepatectomy
    • laparoscopic hepatectomy for primary liver cancer
  • open hepatectomy
    • open hepatectomy for primary liver cancer

Clinical Trial Outcome Measures

Primary Measures

  • The incidence of complications of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,The questionnaire survey
    • Time Frame: Patients with hepatocellular carcinoma who were hospitalized together on October 1, 2017 were studied at the time point before discharge.
    • The incidence of complications, in percent
  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit
    • Time Frame: 1 month after discharge
    • Survival rate, percent
  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit
    • Time Frame: 3 month after discharge
    • Survival rate, percent
  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit
    • Time Frame: 6 month after discharge
    • Survival rate, percent
  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit
    • Time Frame: 1 year after discharge
    • Survival rate, percent
  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit
    • Time Frame: 2 year after discharge
    • Death and recurrence
  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit
    • Time Frame: 3 year after discharge
    • Death and recurrence
  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit
    • Time Frame: 5 year after discharge
    • Survival rate, percent

Secondary Measures

  • Comparison of oxygen uptake days between laparoscopic hepatectomy and laparoscopic hepatectomy for primary liver cancer, unit: day
    • Time Frame: Patients with liver cancer who are hospitalized on 1 October 2017 will be included in the study date.The study time is 1 year.
    • Oxygen uptake days, per day
  • Comparison of ecg monitoring days between laparoscopic hepatectomy and laparoscopic hepatectomy for primary liver cancer Unit: day
    • Time Frame: Patients with liver cancer who are hospitalized on 1 October 2017 will be included in the study date.The study time is 1 year.
    • Guardianship days, unit: days
  • Comparison of the number of replacement drainage bags for primary hepatocellular carcinoma between laparoscopic hepatectomy and laparoscopic hepatectomy, unit: number
    • Time Frame: Patients with liver cancer who are hospitalized on 1 October 2017 will be included in the study date.The study time is 1 year.
    • Compare the number of times to replace the drainage bag, unit: number
  • Comparison of infusion days between laparoscopic hepatectomy and laparoscopic hepatectomy for primary liver cancer Unit: day
    • Time Frame: Patients with liver cancer who are hospitalized on 1 October 2017 will be included in the study date.The study time is 1 year.
    • Infusion days, unit: days
  • Comparison of muscle injection times between laparoscopic hepatectomy and laparoscopic hepatectomy in primary liver cancer: times
    • Time Frame: Patients with liver cancer who are hospitalized on 1 October 2017 will be included in the study date.The study time is 1 year.
    • Muscle injections,Unit: times
  • Comparison between laparoscopic hepatectomy and laparoscopic hepatectomy in primary hepatocellular carcinoma Unit: times
    • Time Frame: Patients with liver cancer who are hospitalized on 1 October 2017 will be included in the study date.The study time is 1 year.
    • Number of subcutaneous injections Unit: times

Participating in This Clinical Trial

Inclusion Criteria

Hepatocellular carcinoma There was no distant metastasis in patients with malignant tumors. Exclusion criteria:

primary tumor diameter > 10cm Thrombosis of portal or inferior vena cava carcinoma Severe organic disease or cirrhosis of the liver Laparoscopic transposition of the abdomen Concomitant coagulant function abnormal patient.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Wuhan Union Hospital, China
  • Provider of Information About this Clinical Study
    • Principal Investigator: Zeng Li, Charge nurse – Wuhan Union Hospital, China
  • Overall Official(s)
    • Li Zeng, Principal Investigator, Department of Hepatobiliary,Union Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
  • Overall Contact(s)
    • Zeng Li, +86 15327374420, zengli2017@hust.edc.cn

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.